PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20356041-4	2010	To evaluate the therapeutic potential of isoliquiritigenin (ILG), we examined its effect on signal transduction via the TRIF-dependent pathway of TLRs.	isoliquiritigenin	41-58	TIR domain containing adaptor molecule 1	Homo sapiens	120-124	
19809799-0	2009	Suppression of the TRIF-dependent signaling pathway of toll-like receptors by isoliquiritigenin in RAW264.7 macrophages.	isoliquiritigenin	78-95	TIR domain containing adaptor molecule 1	Homo sapiens	19-23	
20356041-0	2010	Isoliquiritigenin suppresses the Toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathway of Toll-like receptors by targeting TBK1.	isoliquiritigenin	0-17	TIR domain containing adaptor molecule 1	Homo sapiens	113-117